Table 1.
Risk of ovarian toxicity of antineoplastic drugs.
High risk | Cyclophosphamide, ifosfamide, busulfan, mechlorethamine, melphalan |
---|---|
Intermediate risk | Doxorubicin, epirubicin, cisplatin, docetaxel, paclitaxel |
| |
Low risk | Vincristine, methotrexate, 5-fluorouracil, trastuzumab |